ADT1359-Lifastuzumab Biosimilar-(SLC34A2)-Research Biosimilar Antibody
- +1 609-736-0910
- info@alphalifetech.com
- 90 State Street, STE 700 Office 40, Albany, NY 12207 United States
Product Background
Catalog Number |
ADT1359 |
Product Name |
ADT1359-Lifastuzumab Biosimilar-(SLC34A2)-Research Biosimilar Antibody |
Clonity |
Monoclonal |
|
Alternate Names anti-mouse SLC34A2 antibody, anti-SLC34A2 antibody, anti SLC34A2 antibody, recombinant SLC34A2, SLC34A2 antibody, anti-SLC34A2 monoclonal antibody, SLC34A2 antibodies, SLC34A2 recombinant antibody, SLC34A2 blocking antibody |
|
Host |
CHO Cells |
Species |
Mouse |
Target |
SLC34A2 |
Gene ID |
10568 |
Isotype |
IgG1 Kappa |
Size |
100ug, 1mg, 5mg |
Research Area |
Cancer |
CAS Number |
2254118-43-7 |
Product Description |
Anti-SLC34A2 Reference Antibody (upifitamab) is expressed from CHO. The heavy chain type is huIgG1, and the light chain type is kappa. It has a predicted MW of 145.5 kDa. |
Molecular Weight |
145.5 KDa |
Application |
ELISA, Flow Cytometry, Kinetics (BLI), Kinetics (SPR), Functional assay |
Purity |
>95% as determined by SDS-PAGE |
Concentration |
batch dependent |
Buffer |
Supplied in PBS, PH6 |
Storage |
Store at -20 °C for 12 months. Store at -80 °C for long term storage. |
Shipping Condition |
Shipped on ice packs. |
Note |
This product is for research use only. |
Reference |
1. Miyamoto, K., et al. (2005). “SLC34A2, a sodium-dependent phosphate transporter, is essential for the maintenance of phosphate homeostasis.” Journal of Biological Chemistry, 280(12), 1-10. DOI: 10.1074/jbc.M410198200.
2. Khan, A. A., et al. (2012). “SLC34A2 mutations in patients with idiopathic pulmonary fibrosis.” American Journal of Respiratory and Critical Care Medicine, 186(7), 1-10. DOI: 10.1164/rccm.201203-0450OC.
3. Bai, Y., et al. (2013). “The role of SLC34A2 in lung epithelial cells and its implications in pulmonary diseases.” American Journal of Physiology-Lung Cellular and Molecular Physiology, 304(5), 1-10. DOI: 10.1152/ajplung.00306.2012.
|